Citigroup, Bank of America, and BNP Paribas issued rating updates and price targets for AbbVie stock on August 13, 2026.
2 reports, 2 independent
Updated Sep 22
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup, Bank of America, and BNP Paribas issued rating updates and price targets for AbbVie stock on August 13, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Citigroup
American investment bank and financial services corporation
-
Bank of America
American multinational banking and financial services corporation
-
Paribas
French investment bank (1872-2000)
Related events
- Citigroup influenced market sentiment on Bausch + Lomb Corporation stock on August 6, 2026.
- Bank of America and Citigroup adjusted target prices and raised price objectives for BDX stock.
- Bank of America updated its price objective and rating, while Citigroup reissued a neutral rating on Biogen shares.
- Bank of America, Citigroup, and Royal Bank of Canada issued rating upgrades and price target increases for International Paper.
- Citigroup and Morgan Stanley provided price target and rating updates for Altria on November 4, 2026.